-
Subscribe
for Free
-
-
Our
Cities▾
-
Tech
Channels ▾
-
Meet the
Xconomists ▾
-
-
Senior Vice President of Corporate Development, Avaya
-
Managing Director, Versant Ventures
-
Founder and CEO, Buzzcar
-
Meet All the Xconomists ›
-
Partner, Mohr, Davidow Ventures
-
Chair, Computer Science and Engineering, University of Washington
-
Managing Director, D.E. Shaw and Co., L.P.
-
Executive Partner, Sofinnova Ventures
-
Our
Events ▾
-
|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Promedior, Aveo, Ra, and More Boston Life Sciences Headlines
|
Erin Kutz |
05/18/12 |
Boston
|
|
Mitralign Lands $35,000,000 Series D Round
|
VentureDeal |
05/16/12 |
Boston
|
|
Celladon Garners $43,000,000 New Funding Round
|
VentureDeal |
02/16/12 |
San Diego
|
|
GI Dynamics Raises $85M USD in Aussie IPO
|
Erin Kutz |
08/30/11 |
Boston
|
|
Nevro Raises $58M for Anti-Pain Device
|
Wade Roush |
07/20/11 |
San Francisco
|
|
Nevro Lands $58,000,000 New Financing
|
VentureDeal |
07/20/11 |
San Francisco
|
|
The Bob Langer and Polaris Family Tree: From Acusphere to Momenta to Visterra
|
Gregory T. Huang |
04/19/11 |
Boston
|
|
Astute Extends Series B Funding to $39.5M
|
Bruce V. Bigelow |
03/09/11 |
San Diego
|
|
Astute Medical Obtains $13,000,000 Series B Funding
|
VentureDeal |
03/08/11 |
San Diego
|
|
23andMe Adds $9M to VC Round
|
Luke Timmerman |
01/07/11 |
San Francisco
|
|
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News
|
Erin Kutz |
01/07/11 |
Boston
|
|
SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News
|
Rebecca Zacks |
01/05/11 |
Boston
|
|
Genocea Biosciences Obtains $35,000,000 Series B Funding Round
|
VentureDeal |
01/03/11 |
Boston
|
|
Light Sciences Oncology CEO Exits for New Job; Company Still Waiting for Pivotal Results
|
Luke Timmerman |
11/22/10 |
Seattle
|
|
23andMe Raises $22M
|
Luke Timmerman |
11/09/10 |
San Francisco
|
|
23andMe Lands $22,000,000 Series C Financing Round
|
VentureDeal |
11/09/10 |
San Francisco
|
|
Aquinox Pharma Nabs $25M
|
Luke Timmerman |
06/17/10 |
Seattle
|
|
Ending the Suspense, Celladon’s Gene Therapy Helps Heart Failure Patients in Small Study
|
Luke Timmerman |
06/01/10 |
San Diego
|
|
Breathe Technologies Garners $23,000,000 Series C Round
|
VentureDeal |
05/18/10 |
San Francisco
|
|
Astute Medical Garners $26,500,000 Series B Financing
|
VentureDeal |
05/11/10 |
San Diego
|
|
Celladon’s Gene Therapy Passes Heart Failure Trial; Maintains Suspense on Details
|
Luke Timmerman |
04/28/10 |
San Diego
|
|
Light Sciences Oncology Sits Tight, Awaits Key Cancer Trial Results This Summer
|
Luke Timmerman |
03/01/10 |
Seattle
|
|
GI Dynamics Gets European Approval
|
Ryan McBride |
12/22/09 |
Boston
|
|
Spinal Modulation Garners $27,400,000 Series C Funding
|
VentureDeal |
11/09/09 |
San Francisco
|
|
Direct Flow Medical Lands $40,000,000 Series C Financing
|
VentureDeal |
10/04/09 |
San Francisco
|
|
Celladon, Developer of Gene Therapy for Heart Failure, Secures Part of $24.6M Venture Round
|
Luke Timmerman |
09/15/09 |
San Diego
|
|
Archus Orthopedics, Spine Device Maker that Raised $60M, Shuts Down Amid Cash Crunch
|
Luke Timmerman |
09/03/09 |
Seattle
|
|
NeoTract Obtains $23,700,000 Series B Round
|
VentureDeal |
07/30/09 |
San Francisco
|
|
Yapta Closes Series B, PhysioSonics Scores $2M More, Powerit Talks Strategy, & More Seattle-Area Deals News
|
Gregory T. Huang |
06/30/09 |
Seattle
|
|
Archus Orthopedics, Spine Device Maker, Cuts Jobs Amid Financing Squeeze
|
Luke Timmerman |
05/18/09 |
Seattle
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.